TTM
$26.6B
YoY change
+26.5%
5Y CAGR
+6.2%
Peak year (FY2025)
$26B
Cumulative gross profit
$399B
Gross Profit history chart for Amgen (AMGN) from 2016 to 2025
Latest: $26B
Gross Profit growth chart for Amgen (AMGN) from 2016 to 2025
Latest: +26.5%
Gross Profit history table for Amgen (AMGN) from 1985 to 2025
| FY2025 | $26B | +26.5% | +$5.45B | ||
| FY2024 | $20.6B | +4.0% | +$791M | ||
| FY2023 | $19.8B | -0.7% | -$142M | ||
| FY2022 | $19.9B | +2.0% | +$392M | ||
| FY2021 | $19.5B | +1.3% | +$260M | ||
| FY2020 | $19.3B | +1.4% | +$259M | ||
| FY2019 | $19B | -3.3% | -$640M | ||
| FY2018 | $19.6B | +4.6% | +$866M | ||
| FY2017 | $18.8B | -0.3% | -$49M | ||
| FY2016 | $18.8B | +8.0% | +$1.39B | ||
| FY2015 | $17.4B | +11.5% | +$1.79B | ||
| FY2014 | $15.6B | +2.0% | +$311M | ||
| FY2013 | $15.3B | +6.9% | +$983M | ||
| FY2012 | $14.3B | +9.1% | +$1.19B | ||
| FY2011 | $13.2B | +2.5% | +$322M | ||
| FY2010 | $12.8B | +2.2% | +$282M | ||
| FY2009 | $12.6B | -1.2% | -$156M | ||
| FY2008 | $12.7B | +4.0% | +$484M | ||
| FY2007 | $12.2B | +0.4% | +$50M | ||
| FY2006 | $12.2B | +17.6% | +$1.83B | ||
| FY2005 | $10.3B | +17.3% | +$1.53B | ||
| FY2004 | $8.82B | +25.7% | +$1.8B | ||
| FY2003 | $7.02B | +46.5% | +$2.23B | ||
| FY2002 | $4.79B | +34.0% | +$1.21B | ||
| FY2001 | $3.57B | +9.9% | +$321M | ||
| FY2000 | $3.25B | +9.2% | +$273M | ||
| FY1999 | $2.98B | +22.0% | +$538M | ||
| FY1998 | $2.44B | +12.9% | +$279M | ||
| FY1997 | $2.16B | +7.3% | +$147M | ||
| FY1996 | $2.02B | +17.5% | +$300M | ||
| FY1995 | $1.72B | +17.8% | +$259M | ||
| FY1994 | $1.46B | +22.8% | +$271M | ||
| FY1993 | $1.19B | +27.6% | +$257M | ||
| FY1992 | $929M | +57.8% | +$341M | ||
| FY1991 | $589M | +235.0% | +$413M | ||
| FY1990 | $176M | — | — | ||
| FY1988 | $26.2M | +197.7% | +$17.4M | ||
| FY1987 | $8.8M | +10.0% | +$800K | ||
| FY1986 | $8M | -66.1% | -$15.6M | ||
| FY1985 | $23.6M | — | — |
- FY2025$26B+26.5%
- FY2024$20.6B+4.0%
- FY2023$19.8B-0.7%
- FY2022$19.9B+2.0%
- FY2021$19.5B+1.3%
- FY2020$19.3B+1.4%
- FY2019$19B-3.3%
- FY2018$19.6B+4.6%
- FY2017$18.8B-0.3%
- FY2016$18.8B+8.0%
- FY2015$17.4B+11.5%
- FY2014$15.6B+2.0%
- FY2013$15.3B+6.9%
- FY2012$14.3B+9.1%
- FY2011$13.2B+2.5%
- FY2010$12.8B+2.2%
- FY2009$12.6B-1.2%
- FY2008$12.7B+4.0%
- FY2007$12.2B+0.4%
- FY2006$12.2B+17.6%
- FY2005$10.3B+17.3%
- FY2004$8.82B+25.7%
- FY2003$7.02B+46.5%
- FY2002$4.79B+34.0%
- FY2001$3.57B+9.9%
- FY2000$3.25B+9.2%
- FY1999$2.98B+22.0%
- FY1998$2.44B+12.9%
- FY1997$2.16B+7.3%
- FY1996$2.02B+17.5%
- FY1995$1.72B+17.8%
- FY1994$1.46B+22.8%
- FY1993$1.19B+27.6%
- FY1992$929M+57.8%
- FY1991$589M+235.0%
- FY1990$176M—
- FY1988$26.2M+197.7%
- FY1987$8.8M+10.0%
- FY1986$8M-66.1%
- FY1985$23.6M—
Gross Profit values are taken from Amgen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's current gross profit (TTM) is $26.6B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual gross profit for Amgen (AMGN) came in at $26B – grew 26.5% year-over-year.
Over 2020–2025 (5 years), Amgen gross profit expanded at a +6.2% compound annual rate, sustaining 2 straight years of year-over-year growth.
The record annual gross profit stands at $26B, reached in 2025; the historical low of $8M was recorded in 1986.
Amgen Gross Profit by Year
Amgen Gross Profit 2025: $26B
Amgen posted gross profit of $26B in 2025, grew 26.5% from 2024. This figure represents the highest annual value in the available history.
Amgen Gross Profit 2024: $20.6B
In 2024, Amgen reported gross profit of $20.6B, edged up 4.0% from 2023.
Amgen Gross Profit 2023: $19.8B
Amgen gross profit in 2023 was $19.8B, edged down 0.7% below 2022.
Amgen Gross Profit 2022: $19.9B
2022's gross profit for Amgen came in at $19.9B, edged up 2.0% from 2021.
Amgen Gross Profit 2021: $19.5B
Amgen gross profit in 2021 was $19.5B.
See more financial history for Amgen (AMGN).
Sector peers by Gross Profit
Healthcare peers of Amgen (AMGN), ranked by their latest gross profit
| $82.9B | |
| $68.6B | |
| $54.6B | |
| $46.7B | |
| $43B | |
| $39B | |
| $24.6B | |
| $16.8B |
- $82.9B
- $68.6B
- $54.6B
- $46.7B
- $43B
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks
- Dividend Profile2.53% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.